SCHEMBL12423448

SCHEMBL12423448

CNC(=O)c1ccc(-c2ccc(-c3ccnc(Nc4cccc(C(C)O)c4)n3)s2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 8/20 0.58
MAPK8 P45983 2/20 0.47
PIK3CG P48736 2/20 0.47
GSK3B P49841 2/20 0.47
CAMKK2 Q96RR4 2/20 0.47
ABL1 P00519 5/20 0.46
BCR P11274 5/20 0.46
PDGFRB P09619 3/20 0.46
PDGFRA P16234 3/20 0.46
CDK2 P24941 2/20 0.46
JAK2 O60674 1/20 0.46
IKBKB O14920 1/20 0.46
CDC7 O00311 1/20 0.45
CDK19 Q9BWU1 1/20 0.45
ABL2 P42684 1/20 0.44
SRC P12931 2/20 0.44
PRKCA P17252 2/20 0.44
PRKCD Q05655 2/20 0.44
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12423428 0.87 CAMK2D (0.49) CAMK2DMAPK8PIK3CGGSK3BCAMKK2
SCHEMBL12423714 0.86 CAMK2D (0.52) CAMK2DMAPK8PIK3CGGSK3BCAMKK2
SCHEMBL12423475 0.85 CAMK2D (0.53) CAMK2DPIK3CGABL1BCRCDK2
SCHEMBL12423765 0.85 ABL1 (0.52) CAMK2DPIK3CGABL1BCRCDK2
SCHEMBL12423462 0.84 SYK (0.53) CAMK2DMAPK8PIK3CGGSK3BCAMKK2
SCHEMBL12423746 0.83 ABL1 (0.56) ABL1BCRPDGFRBPDGFRAABL2
SCHEMBL12423444 0.83 CDK1 (0.56) CDK2JAK2IKBKBPRKCZCCNT1
SCHEMBL12423471 0.82 CAMK2D (0.54) CAMK2DPIK3CGABL1BCRPDGFRB
SCHEMBL12423686 0.81 IKBKB (0.52) CAMK2DMAPK8PIK3CGGSK3BCAMKK2
SCHEMBL2196144 0.81 IKBKB (0.47) CAMK2DMAPK8PIK3CGGSK3BCAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977481-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2011-07-12 US disclosed
US-7977481-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2011-07-12 US disclosed
US-20100305128-A1 Pyrimidinyl-Thiophene Kinase Modulators ARNOLD WILLIAM D 2010-12-02 US disclosed
US-20100305128-A1 Pyrimidinyl-Thiophene Kinase Modulators ARNOLD WILLIAM D 2010-12-02 US disclosed
US-7803806-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-09-28 US disclosed
US-7803806-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-09-28 US disclosed
US-20070117800-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 US disclosed
US-20070117800-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305128-A1 Pyrimidinyl-Thiophene Kinase Modulators MAP3K20, MAP3K6, MAP4K2 CAMK2D 313/4885MAPK8 237/4885PIK3CG 280/4885
US-20070117800-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS MAP3K20, MAP3K6, MAP4K2 CAMK2D 313/4885MAPK8 237/4885PIK3CG 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.